These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
285 related articles for article (PubMed ID: 7040297)
1. Oligodendrocytes: the putative target cells of multiple sclerosis. Abramsky O Isr J Med Sci; 1982 Jan; 18(1):149-58. PubMed ID: 7040297 [No Abstract] [Full Text] [Related]
2. The oligodendroglial cell: biology and immunology and relationship to multiple sclerosis. Bartlett PF; Mackay IR J Clin Lab Immunol; 1983 May; 11(1):1-7. PubMed ID: 6348293 [TBL] [Abstract][Full Text] [Related]
3. Antibodies to oligodendroglia in patients with multiple sclerosis. Abramsky O; Lisak RP; Silberberg DH; Pleasure DE N Engl J Med; 1977 Dec; 297(22):1207-11. PubMed ID: 335246 [TBL] [Abstract][Full Text] [Related]
4. [Antibodies to myelin cerebrosides and their role in the pathogenesis of autoimmune demyelinating diseases (review)]. Taranova NP; Kirchik OS Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(12):1863-72. PubMed ID: 3911691 [No Abstract] [Full Text] [Related]
6. [In vitro study of the cytotoxicity of sera from patients with multiple sclerosis and other neurological diseases to cultured rat oligodendrocytes]. Hirayama M; Kawai K; Iida M; Sobue I Rinsho Shinkeigaku; 1986 Aug; 26(8):835-40. PubMed ID: 3802676 [No Abstract] [Full Text] [Related]
7. [Demyelination and autoimmunity]. Lebar R Pathol Biol (Paris); 1987 Mar; 35(3):275-83. PubMed ID: 3295694 [TBL] [Abstract][Full Text] [Related]
8. Oligodendrocytes, key cells in myelination and target in demyelinating diseases. Bologa L J Neurosci Res; 1985; 14(1):1-20. PubMed ID: 2410623 [No Abstract] [Full Text] [Related]
9. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis. Raine CS Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955 [No Abstract] [Full Text] [Related]
11. Cell-mediated immunity to isolated human oligodendroglia in multiple sclerosis. Myers LW; Ellison GW; Fewster ME; Wolfgram F Trans Am Neurol Assoc; 1975; 100():107-9. PubMed ID: 1226591 [No Abstract] [Full Text] [Related]
12. Multiple sclerosis: autoimmune disease. Chinen A; Yokoyama M Hawaii Med J; 1971; 30(6):464-71. PubMed ID: 5156962 [No Abstract] [Full Text] [Related]
13. Antibodies to oligodendroglia in multiple sclerosis. Abramsky O; Lisak RP; Silberberg DH; Pleasure DE N Engl J Med; 1978 Mar; 298(13):743. PubMed ID: 628401 [No Abstract] [Full Text] [Related]
14. Multiple sclerosis serum and cerebrospinal fluid immunoglobulin binding to Fc receptors of oligodendrocytes. Ma BI; Joseph BS; Walsh MJ; Potvin AR; Tourtellotte WW Ann Neurol; 1981 Apr; 9(4):371-7. PubMed ID: 6452854 [TBL] [Abstract][Full Text] [Related]
15. Oligodendrocyte staining by multiple sclerosis serum is nonspecific. Traugott U; Snyder S; Raine CS Ann Neurol; 1979 Jul; 6(1):13-20. PubMed ID: 389147 [TBL] [Abstract][Full Text] [Related]
16. Experimental allergic encephalomyelitis: serum immunoglobulin binds to myelin and oligodendrocytes in cultured tissue: ultrastructural-immunoperoxidase observations. Johnson AB; Raine CS; Bornstein MB Lab Invest; 1979 May; 40(5):568-75. PubMed ID: 374865 [No Abstract] [Full Text] [Related]
17. [Role of neuroallergy in the pathogenesis of multiple sclerosis]. Vilkov GA; Martirosian VV Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(2):206-9. PubMed ID: 3885657 [TBL] [Abstract][Full Text] [Related]